Last reviewed · How we verify
phenylpropanol
phenylpropanol is a drug. It is currently in unknown development for Allergic conjunctivitis, Allergic rhinitis, Common cold.
Phenylpropanol is a small molecule with synonyms including alpha-ethylbenzyl alcohol, ethylbenzyl alcohol, and FEMA No. 2884. It is listed in ChEMBL, a database of bioactive molecules, but no specific information is available on its clinical indications or mechanism of action.
At a glance
| Generic name | phenylpropanol |
|---|---|
| Therapeutic area | Infectious Disease |
| Phase | unknown |
Approved indications
- Allergic conjunctivitis
- Allergic rhinitis
- Common cold
- Cough
- Influenza-like symptoms
- Nasal congestion
- Nasal discharge
- Rhinitis
- Seasonal allergic rhinitis
- Sinus headache
- Sneezing
- Vasomotor rhinitis
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- phenylpropanol CI brief — competitive landscape report
- phenylpropanol updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about phenylpropanol
What is phenylpropanol?
phenylpropanol is a pharmaceutical drug, indicated for Allergic conjunctivitis, Allergic rhinitis, Common cold.
What is phenylpropanol used for?
phenylpropanol is indicated for Allergic conjunctivitis, Allergic rhinitis, Common cold, Cough, Influenza-like symptoms.
What development phase is phenylpropanol in?
phenylpropanol is in unknown.
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Infectious Disease
- Indication: Drugs for Allergic conjunctivitis
- Indication: Drugs for Allergic rhinitis
- Indication: Drugs for Common cold
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing